CNS disease of MS/EAE initiates with the infiltration of myelin specific immune cells and expression of inflammatory mediators (TNFα, IL-1β, IFN- γ and IL-17), demyelination and axonal degeneration leading to physical disability observed in patients with MS [64–66]. Here, IL17A is linked to myeloid sarcoma.